Analysis of 2009 pandemic influenza a/h1n1 outcomes in 19 european countries: Association with completeness of national strategic plans

BMJ Open

Volumn 3, Issue 3, 2013, Pages

  Meeyai, Aronrag ^a,b   Cooper, Ben S ^a,c   Coker, Richard ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE;

ARTICLE; CORRELATIONAL STUDY; GREECE; HUMAN; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; INTERPERSONAL COMMUNICATION; MEDICAL SERVICE; NORWAY; OUTCOME ASSESSMENT; PANDEMIC INFLUENZA; RETROSPECTIVE STUDY; SEASON; STRATEGIC PLANNING; UNITED KINGDOM;

EID: 84876145416     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-002253     Document Type: Article

References (30)

1. Presanis AM, De Angelis D, The New York City Swine Flu Investigation Team, et al. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: A bayesian analysis. PLoS Med 2009;6:e1000207.
2. Sachedina N, Donaldson LJ. Paediatric mortality related to pandemic influenza A H1N1 infection in England: An observational population-based study. Lancet 2010;376:1846-52.
3. Update on evaluation of the response to pandemic (H1N1) 2009. WHO: Regional office for Europe. http://www.euro.who.int/en/what-we-do/health-topics/ diseases-and-conditions/influenza/pandemic-h1n1-2009/whoeurope-news-and-updates/ update-on-evaluation-of-the-responseto-pandemic-h1n1-2009 (accessed 9 Nov 2012).
4. Report on evaluation of the management of H1N1 influenza in 2009-2010 in the EU (2010/2153(INI)). Committee on the Environment, Public Health and Food Safety. http://www.europarl. europa.eu/sides/getDoc.do?type= REPORT&reference=A7-2011-0035&language=EN (accessed 9 Nov 2012)
5. Animal and pandemic influenza: A framework for sustaining momentum. Fifth Global Progress Report 2010. United Nations System Influenza Coordination and the World Bank. http://un-influenza.org/files/Global%20Progress%20Report%202010. pdf (accessed 9 Nov 2012).
6. WHO Checklist for influenza epidemic preparedness. WHO/CDS/CSR/GIP/2005. 4. Geneva: World Health Organization, 2005.
7. Pandemic influenza preparedness in the EU: Technical Report | January 2007. ECDC. http://www.ecdc.europa.eu/en/publications/Publications/0701-TER- Pandemic-Influenza-Preparedness.pdf (accessed 9 Nov 2012).
8. Mounier-Jack S, Coker RJ. How prepared is Europe for pandemic influenza? Analysis of national plans. Lancet 2006;367:1405-11.
9. Pandemic preparedness plans. ECDC. http://www.ecdc.europa.eu/en/ healthtopics/pandemic-preparedness/national-pandemic-preparedness-plans/Pages/ national-pandemic-preparedness-plans. aspx (accessed 9 Nov 2012).
10. European Influenza Surveillance System (EISS). ECDC. http://ecdc. europa.eu/en/healthtopics/seasonal-influenza/epidemiological-data/Pages/ archive-weekly-electronic-bulletins.aspx (accessed 9 Nov 2012).
11. The National Centre of Epidemiology of the Italian National Institute of Health. Istituto Superiore di Sanità. http://www.iss.it/iflu/(accessed 9 Nov 2012)
12. Influenza-like illness. Réseau Sentinelles. http://websenti.b3e. jussieu. fr/sentiweb/index.php?rub=67&mal=3 (accessed 12 Nov 2011).
13. Halloran ME, Ferguson NM, Eubank S, et al. Modeling targeted layered containment of an influenza pandemic in the United States. Proc Natl Acad Sci USA 2008;105:4639-44. (Pubitemid 351753799)
14. Hatchett RJ, Mecher CE, Lipsitch M. Public health interventions and epidemic intensity during the 1918 influenza pandemic. Proc Natl Acad Sci USA 2007;104:7582-7. (Pubitemid 47185949)
15. Glass RJ, Glass LM, Beyeler WE, et al. Targeted social distancing design for pandemic influenza. Emerg Infect Dis 2006;12:1671-81. (Pubitemid 44674242)
16. Bootsma MC, Ferguson NM. The effect of public health measures on the 1918 influenza pandemic in U.S. cities. Proc Natl Acad Sci USA 2007;104:7588-93. (Pubitemid 47185950)
17. Ferguson NM, Cummings DA, Fraser C, et al. Strategies for mitigating an influenza pandemic. Nature 2006;442:448-52. (Pubitemid 44264793)
18. Shaman J, Pitzer VE, Viboud C, et al. Absolute humidity and the seasonal onset of influenza in the continental United States. PLoS Biol 2010;8:e1000316.
19. Ghani AC, Baguelin M, Griffin J, et al. The early transmission dynamics of H1N1pdm influenza in the United Kingdom. PLoS Curr 2009;1:RRN1130. [revised 13 Jun 2010].
20. Halloran ME, Hayden FG, Yang Y, et al. Antiviral effects on influenza viral transmission and pathogenicity: Observations from household-based trials. Am J Epidemiol 2007;165:212-21. (Pubitemid 46096383)
21. Goldstein E, Dushoff J, Ma J, et al. Reconstructing influenza incidence by deconvolution of daily mortality time series. Proc Natl Acad Sci USA 2009;106:21825-9.
22. Aguilera JF, Paget WJ, Mosnier A, et al. Heterogeneous case definitions used for the surveillance of influenza in Europe. Eur J Epidemiol 2003;18:733-6.
23. Paget J, Marquet R, Meijer A, et al. Influenza activity in Europe during eight seasons (1999-2007): An evaluation of the indicators used to measure activity and an assessment of the timing, length and course of peak activity (spread) across Europe. BMC Infect Dis 2007;7:141.
24. Siddiqui MR, Edmunds WJ. Cost-effectiveness of antiviral stockpiling and near-patient testing for potential influenza pandemic. Emerg Infect Dis 2008;14:267-74. (Pubitemid 351213677)
25. Nishiura H, Oshitani H. Effects of vaccination against pandemic (H1N1) 2009 among Japanese children. Emerg Infect Dis 2011;17:746-7.
26. Flasche S, Hens N, Boëlle P-Y, et al. Different transmission patterns in the early stages of the influenza A(H1N1) pandemic: A comparative analysis of 12 European countries. Epidemics 2011;3:125-33.
27. Birrell PJ, Ketsetzis G, Gay NJ, et al. Bayesian modeling to unmask and predict influenza A/H1N1pdm dynamics in London. Proc Natl Acad Sci USA 2011;108:18238-43.
28. Baguelin M, Hoek AJ, Jit M, et al. Vaccination against pandemic influenza A/H1N1v in England: A real-time economic evaluation. Vaccine 2010;28:2370-84.
29. Johnson H, Meeyai A, Coker R. Potential for greater coherence in European influenza surveillance. Eur J Public Health 2010;20:488-9.
30. Lipsitch M, Hayden FG, Cowling BJ, et al. How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count. Lancet 2009;374:1209-11.